The Northern Nephrology and Hypertension team.

Slowing Kidney Disease

NNH Clinical Protocol

Slowing Kidney Disease

Small changes today can move dialysis years into the future.

Developed by Craig G. Hurwitz, MD

📚 Patient Educator📄 Evidence-based, not predictive⚠️ From Northern Nephrology & Hypertension

Step 1

[Picker step title — e.g. Select the procedure / Select the indication]

[One sentence guiding the clinician on what they're choosing.]

[OPTION_1_TITLE][short tag][OPTION_2_TITLE][short tag][OPTION_3_TITLE][short tag][OPTION_4_TITLE][short tag][OPTION_5_TITLE][short tag][OPTION_6_TITLE][short tag]

Recommendation

—

Choose a different procedure

This tool is educational and not intended to predict individual outcomes. Verify allergies, drug interactions, and renal/hepatic dose adjustments before administration. [Replace this sentence with protocol-appropriate caveats about evidence quality, regulatory grade, or guideline limitations.]

Reference

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314.

Heerspink HJL, Stefánsson BV, Correa-Rotter R, et al. Dapagliflozin in patients with chronic kidney disease (DAPA-CKD). N Engl J Med. 2020;383(15):1436-1446. Bakris GL, Agarwal R, Anker SD, et al. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes (FIDELIO-DKD). N Engl J Med. 2020;383(23):2219-2229.

Kidney care starts here!

Call: 518-324-4000

Patient Portal

Slowing Kidney Disease

Slowing Kidney Disease

[Picker step title — e.g. Select the procedure / Select the indication]

—

Reference

For Patients

For Professionals

For NNH Staff

Main Office

Office Hours: Mon-Fri 9AM-5PM

© 2026 Craig G. Hurwitz, MD — Northern Nephrology & Hypertension